Zean Zhao

744 total citations
29 papers, 552 citations indexed

About

Zean Zhao is a scholar working on Nephrology, Molecular Biology and Pharmacology. According to data from OpenAlex, Zean Zhao has authored 29 papers receiving a total of 552 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Nephrology, 12 papers in Molecular Biology and 8 papers in Pharmacology. Recurrent topics in Zean Zhao's work include Gout, Hyperuricemia, Uric Acid (19 papers), Pharmacological Effects of Natural Compounds (6 papers) and Case Reports on Hematomas (5 papers). Zean Zhao is often cited by papers focused on Gout, Hyperuricemia, Uric Acid (19 papers), Pharmacological Effects of Natural Compounds (6 papers) and Case Reports on Hematomas (5 papers). Zean Zhao collaborates with scholars based in China and Poland. Zean Zhao's co-authors include Jianxin Pang, Ting Wu, Ying Cao, Pingzheng Zhou, Yuanxin Tian, Yongmei Li, Jian Luo, Yanyu Chen, Jiang Yu and Lu Li and has published in prestigious journals such as Journal of Agricultural and Food Chemistry, Journal of Medicinal Chemistry and Biochemical Pharmacology.

In The Last Decade

Zean Zhao

27 papers receiving 541 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zean Zhao China 15 372 234 165 97 93 29 552
Ling Guo China 14 135 0.4× 189 0.8× 41 0.2× 58 0.6× 56 0.6× 31 602
Yonger Chen China 14 116 0.3× 287 1.2× 124 0.8× 80 0.8× 52 0.6× 20 609
Bingbing Zhu China 14 137 0.4× 238 1.0× 44 0.3× 46 0.5× 58 0.6× 50 609
Wenhao Liao China 11 96 0.3× 227 1.0× 72 0.4× 41 0.4× 39 0.4× 33 436
Enchao Zhou China 12 105 0.3× 204 0.9× 37 0.2× 50 0.5× 46 0.5× 25 487
Hua Lin China 15 185 0.5× 205 0.9× 66 0.4× 60 0.6× 55 0.6× 19 572
Yanting You China 13 66 0.2× 234 1.0× 86 0.5× 42 0.4× 36 0.4× 36 517
Lichao Zhang China 11 58 0.2× 181 0.8× 76 0.5× 52 0.5× 51 0.5× 51 460
Toshihiro Asai Japan 13 103 0.3× 208 0.9× 44 0.3× 62 0.6× 73 0.8× 22 659
Gang Cao China 9 107 0.3× 228 1.0× 50 0.3× 25 0.3× 23 0.2× 17 439

Countries citing papers authored by Zean Zhao

Since Specialization
Citations

This map shows the geographic impact of Zean Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zean Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zean Zhao more than expected).

Fields of papers citing papers by Zean Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zean Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zean Zhao. The network helps show where Zean Zhao may publish in the future.

Co-authorship network of co-authors of Zean Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Zean Zhao. A scholar is included among the top collaborators of Zean Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zean Zhao. Zean Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Y. D., Sheng Zhang, Tai‐Ping Sun, et al.. (2025). Hardware‐Efficient Quantum Random Access Memory Design with a Native Gate Set on Superconducting Platforms. Advanced Quantum Technologies. 8(5). 3 indexed citations
2.
3.
Huang, Rongrong, Hong Wang, Shuqin Zhang, et al.. (2025). 5-O-Methylvisammioside, a novel inhibitor of CNT2, improves hyperuricemia by inhibiting intestinal purine nucleoside absorption with a safe profile. Biochemical Pharmacology. 242(Pt 1). 117236–117236.
4.
Zhao, Zean, et al.. (2025). Recent Progress in the Development of Glucose Transporter (GLUT) Inhibitors. Journal of Medicinal Chemistry. 68(2). 1033–1050. 4 indexed citations
5.
Zhao, Zean, Xinhua Chen, Jiajun Luo, et al.. (2024). Design, synthesis and bioactivity evaluation of isobavachin derivatives as hURAT1 inhibitors for hyperuricemia agents. European Journal of Medicinal Chemistry. 277. 116753–116753. 3 indexed citations
6.
Ye, Wenjie, Zhenkun Wu, Yunjie Chen, et al.. (2024). Discovery of cyanidin-3-O-galactoside as a novel CNT2 inhibitor for the treatment of hyperuricemia. Bioorganic Chemistry. 154. 108108–108108. 3 indexed citations
7.
Li, Lu, Jian Luo, Zijun Xie, et al.. (2024). Piperine Improves Hyperuricemic Nephropathy by Inhibiting URAT1/GLUT9 and the AKT-mTOR Pathway. Journal of Agricultural and Food Chemistry. 72(12). 6565–6574. 17 indexed citations
8.
Luo, Jiajun, Xinhua Chen, Zean Zhao, et al.. (2023). Mechanism of anti-hyperuricemia of isobavachin based on network pharmacology and molecular docking. Computers in Biology and Medicine. 155. 106637–106637. 16 indexed citations
9.
10.
Yang, Yang, Leqi Zhang, Yongmei Li, et al.. (2023). L-carnitine attenuated hyperuricemia-associated left ventricular remodeling through ameliorating cardiomyocytic lipid deposition. Frontiers in Pharmacology. 14. 1016633–1016633. 5 indexed citations
11.
Zhao, Zean, Hui Liao, Yongjun Chen, et al.. (2022). Mutation in Transmembrane Domain 8 of Human Urate Transporter 1 Disrupts Uric Acid Recognition and Transport. ACS Omega. 7(38). 34621–34631. 7 indexed citations
12.
Zhao, Zean, Jin Liu, L. Yuan, et al.. (2022). Discovery of novel benzbromarone analogs with improved pharmacokinetics and benign toxicity profiles as antihyperuricemic agents. European Journal of Medicinal Chemistry. 242. 114682–114682. 14 indexed citations
13.
Huang, Peiying, Ping Yan, Zean Zhao, et al.. (2021). Versatile Nanodrugs Containing Glutathione and Heme Oxygenase 1 Inhibitors Enable Suppression of Antioxidant Defense System in a Two‐Pronged Manner for Enhanced Photodynamic Therapy. Advanced Healthcare Materials. 10(19). e2100770–e2100770. 34 indexed citations
14.
Zhao, Zean, Jin Liu, Jian Luo, et al.. (2021). Discovery of novel verinurad analogs as dual inhibitors of URAT1 and GLUT9 with improved Druggability for the treatment of hyperuricemia. European Journal of Medicinal Chemistry. 229. 114092–114092. 29 indexed citations
15.
Chen, Xinhua, Zean Zhao, Jiajun Luo, et al.. (2021). Novel natural scaffold as hURAT1 inhibitor identified by 3D-shape-based, docking-based virtual screening approach and biological evaluation. Bioorganic Chemistry. 117. 105444–105444. 16 indexed citations
16.
Zhao, Zean, Jiang Yu, Ting Wu, et al.. (2021). CDER167, a dual inhibitor of URAT1 and GLUT9, is a novel and potent uricosuric candidate for the treatment of hyperuricemia. Acta Pharmacologica Sinica. 43(1). 121–132. 36 indexed citations
17.
Zhao, Tong, Qing Meng, Yanyu Chen, et al.. (2020). Novel Human Urate Transporter 1 Inhibitors as Hypouricemic Drug Candidates with Favorable Druggability. Journal of Medicinal Chemistry. 63(19). 10829–10854. 41 indexed citations
18.
Zhao, Zean, Jiang Yu, Lu Li, et al.. (2020). Structural Insights into the Atomistic Mechanisms of Uric Acid Recognition and Translocation of Human Urate Anion Transporter 1. ACS Omega. 5(51). 33421–33432. 25 indexed citations
19.
Chen, Yanyu, Zean Zhao, Yongmei Li, et al.. (2020). Characterizations of the Urate Transporter, GLUT9, and Its Potent Inhibitors by Patch-Clamp Technique. SLAS DISCOVERY. 26(3). 450–459. 20 indexed citations
20.
Zhao, Tingting, Zean Zhao, Shan Chang, et al.. (2019). Two- and three-dimensional QSAR studies on hURAT1 inhibitors with flexible linkers: topomer CoMFA and HQSAR. Molecular Diversity. 24(1). 141–154. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ling Guo Breakdown of academic impact, for papers by Yonger Chen Breakdown of academic impact, for papers by Bingbing Zhu Breakdown of academic impact, for papers by Wenhao Liao Breakdown of academic impact, for papers by Enchao Zhou Breakdown of academic impact, for papers by Hua Lin Breakdown of academic impact, for papers by Yanting You Breakdown of academic impact, for papers by Lichao Zhang Breakdown of academic impact, for papers by Toshihiro Asai Breakdown of academic impact, for papers by Gang Cao
Rankless by CCL
2026